Genomic profiling identifies alterations in TGFβ signaling through loss of TGFβ receptor expression in human renal cell carcinogenesis and progression

Oncogene

Volumn 22, Issue 39, 2003, Pages 8053-8062

  Copland, John A ^a   Luxon, Bruce A ^a   Ajani, Laila ^b   Maity, Tapati ^b   Campagnaro, Erica ^a   Guo, Huiping ^a   LeGrand, Shauna N ^a   Tamboli, Pheroze ^b   Wood, Christopher G ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Carcinogenesis; Metastasis; Renal cell carcinoma; TGF ; Type II TGF receptor; Type III TGF receptor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA3 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL ANCHORAGE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; KIDNEY CARCINOMA; METASTASIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0344255672     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206835     Document Type: Article

References (43)

1. Abreu JG, Ketpure NI, Reversade B and De Robertis EM. (2002). Nat. Cell Biol., 4, 599-604.
2. Akhurst RJ and Derynck R. (2001). Trends Cell Biol., 11, S44-S51.
3. Allander SV, Nupponen NN, Ringner M, Hostetter G, Maher GW, Goldberger N, Chen Y, Carpten J, Elkahloun AG and Meltzer PS. (2001). Cancer Res., 61, 8624-8628.
4. Blobe GC, Scheimann WP, Pepin M-C, Beauchemin M, Moustakas A, Lodish HF and O'Connor-McCourt MD. (2001). J. Biol. Chem., 276, 24627-24637.
5. Bottinger EP and Bitzer M. (2002). J. Am. Soc. Nephrol., 13, 2600-2610.
6. Boyd FT and Massague J. (1989). J. Biol. Chem., 264, 2272-2278.
7. Boyer AS and Runyan RB. (2001). Dev. Dynam., 221, 454-459.
8. Cardillo MR, Lazzereschi D, Gandini O, Di Silverio F and Colletta G. (2001). Anal. Quant. Cytol. Histol., 23, 109-117.
9. Chen C, Wang X-F and Sun L. (1997). J. Biol. Chem., 272, 12862-12868.
10. Copland JA, Davies PJ, Shipley GL, Wood CG, Luxon BA and Urban RJ. (2003). Recent Prog. Horm. Res., 58, 25-53.
11. Dedir A, Ozener C, Adm B and Emerk K. (1996). Clin. Biochem., 29, 385-388.
12. Deng X, Bellis S, Yan Z and Friedman E. (1999). Cell Growth Differ., 10, 11-18.
13. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y and Su YA. (1996). Nat. Genet., 14, 457-460.
14. Derynck R, Zhang Y and Feng X-H. (1998). Cell, 95, 737-740.
15. Engel JD, Kundu SD, Yang T, Lang S, Goodwin S, Janulis L, Cho JS, Chang J, Kim SJ and Lee C. (1999). Urology, 54, 164-170.
16. Esparza-Lopez J, Montiel JL, Vilchis-Landeros MM, Okadomes T, Miyazono K and Lopez-Casillas F. (2001). J. Biol. Chem., 276, 14588-14596.
17. Gilbert RE, Cox A, Wu LL, Allen TJ, Hulthen UL, Jerums G and Cooper ME. (1998). Diabetes, 47, 414-422.
18. Gold LI. (1999). Crit. Rev. Oncogenesis, 10, 303-360.
19. Grossman HB, Wedemeyer G and Ren L. (1985). J. Surg. Oncol., 28, 237-244.
20. Hegele A, Varga Z, von Knobloch R, Heidenreich A, Kropf J and Hofmann R. (2003). Urol. Res., 30, 126-129.
21. Jemal A, Murray TSA, Ghafoor A, Ward E and Thun MJ. (2003). CA Cancer J. Clin., 53, 5-26.
22. Kim SJ, Im YH, Markowitz SD and Bang YJ. (2000). Cytokine Growth Factor Rev., 11, 159-168.
23. Kinzler KW and Vogelstein B. (1996). Cell, 87, 159-170.
24. Kundu SD, Kim IY, Zelner D, Janulis L, Goodwin S, Engel JD and Lee C. (1998). J. Urol., 160, 1883-1888.
25. Laiho M, Weis MB and Massague I. (1990). J. Biol. Chem., 265, 18518-18524.
26. Lopez-Casilas F, Cheifetz S, Doody J, Andres JL, Lane WS and Massague J. (1991). Cell, 67, 785-795.
27. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW and Vogelstein B, et al. (1995). Science, 268, 1336-1338.
28. Massague J and Wotton D. (2000). EMBO J., 19, 1745-1754.
29. Maustakas A, Souchelnytksyi S and Heldin CH. (2001). J. Cell. Sci., 114, 4359-4369.
30. Ramp U, Jaquet K, Reinecke P, Nitsch T, Gabbert HE and Gerharz CD. (1997a). Lab. Invest., 76, 739-749.
31. Ramp U, Jaquet K, Reinecke P, Schardt C, Friebe U, Nitsch T, Marx N, Gabbert HE and Gerharz CD. (1997b). J. Urol., 157, 2345-2350.
32. Sakharova OV, Taal MW and Brenner BM. (2001). Curr. Opin. Nephrol. Hypertens., 10, 727-738.
33. Schena M, Shalon D, Davis RW and Brown PO. (1995). Science, 270, 467-470.
34. Schiemann WP, Blobe GC, Kalume DE, Pandey A and Lodish HF. (2002). J. Biol. Chem., 277, 27367-27377.
35. Sens DA, Detrisac CJ, Sens MA, Rossi MR, Wenger SL and Todd JH. (1999). Exp. Nephrol., 7, 344-352.
36. Sun L and Chen C. (1997). J. Biol. Chem., 272, 22367-25372.
37. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB and The BT. (2001). Proc. Natl. Acad. Sci. USA, 98, 9754-9759.
38. ten Dijke P, Miyazono K and Heldin CH. (2000). Trends Biochem. Sci., 25, 64-70.
39. Terzi F, Burtin M, Hekmati M, Federici P, Grimber F, Briand P and Friedlander B. (2000). J. Clin. Invest., 106, 225-234.
40. Trifillis AL. (1999). Exp. Nephrol., 7, 353-359.
41. Wogensen L, Nielsen CB, Hjorth P, Rasmussen LM, Nielsen AH, Gross K, Sarvetnick N and Ledet T. (1999). Diabetes, 48, 182-192.
42. Wunderlich H, Steiner T, Kosmehl H, Junker U, Reinhold D, Reichelt O, Zermann DH and Schubert J. (1998). Urol. Int., 60, 205-207.
43. Zhang Y and Derynck R. (1999). Trends Cell Biol., 9, 274-279.